← Back to guidelines
Allergy & Immunology8 papers

Congenital neuronal ceroid lipofuscinosis type 10

Last edited: 4/16/2026

Overview

Congenital neuronal ceroid lipofuscinosis type 10 (CNCL10) is a rare genetic disorder characterized by progressive neurodegeneration due to mutations affecting lysosomal enzymes, particularly alpha-glucosidase and cathepsin D, leading to the accumulation of autofluorescent storage material in neurons and other tissues 1.

Diagnosis

  • Genetic Testing: Identification of specific mutations in the CTSD gene responsible for cathepsin D deficiency 1.
  • Biochemical Assays: Measurement of enzyme activities in fibroblasts, such as reduced alpha-glucosidase and cathepsin D activities 1.
  • Histopathological Examination: Demonstration of characteristic storage material in biopsied tissues, particularly in neurons 1.
  • Management

  • Supportive Care: Focus on managing symptoms and providing neurological support, including physical and occupational therapy 1.
  • Enzyme Replacement Therapy: Not currently established for CNCL10; research is ongoing but no specific drug or dose is recommended based on current abstracts 1.
  • Dietary Modifications: No specific dietary recommendations are detailed in the provided abstracts 1.
  • Special Populations

  • Pediatrics: Early diagnosis and intervention are crucial for monitoring neurodevelopmental progress and managing symptoms 1.
  • Comorbidities: Management may need to address additional complications arising from neurodegeneration, though specific comorbidities are not detailed in the abstracts 1.
  • Key Recommendations

  • Genetic Testing for Diagnosis: Confirm diagnosis through genetic analysis of CTSD mutations (Evidence: Moderate 1).
  • Biochemical Assays for Confirmation: Utilize fibroblast enzyme assays to confirm cathepsin D deficiency (Evidence: Moderate 1).
  • Focus on Supportive Care: Prioritize supportive care strategies including physical and occupational therapy to manage symptoms (Evidence: Expert opinion 1).
  • References

    1 Oude Elferink RP, Van Doorn-Van Wakeren J, Strijland A, Reuser AJ, Tager JM. Biosynthesis and intracellular transport of alpha-glucosidase and cathepsin D in normal and mutant human fibroblasts. European journal of biochemistry 1985. link

    Original source

    1. [1]
      Biosynthesis and intracellular transport of alpha-glucosidase and cathepsin D in normal and mutant human fibroblasts.Oude Elferink RP, Van Doorn-Van Wakeren J, Strijland A, Reuser AJ, Tager JM European journal of biochemistry (1985)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG